Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089336311> ?p ?o ?g. }
- W3089336311 endingPage "315" @default.
- W3089336311 startingPage "307" @default.
- W3089336311 abstract "Androgen deprivation therapy (ADT) is the mainstay for the management of metastatic prostate cancer. Available pharmaceutical ADTs include gonadotropin-releasing hormone (GnRH) agonists and antagonists. Here, real-world data are presented from the UK general practitioner Optimum Patient Care Research Database. The study investigated the hypothesis that GnRH antagonists have lower cardiac event rates than GnRH agonists.The incidence of cardiac events following initiation of GnRH antagonist or agonist therapy was investigated in a population-based cohort study conducted in UK primary care between 2010 and 2017.Analysis of real-world data from the UK primary care setting showed that relative risk of experiencing cardiac events was significantly lower with degarelix, a GnRH antagonist, compared with GnRH agonists (risk ratio: 0.39 [95% confidence interval 0.191, 0.799]; p = 0.01). Patients that received degarelix as first-line treatment switched treatment more frequently (33.7%), often to a GnRH agonist, than those who initiated treatment with a GnRH agonist (6.7-18.6%).Screening for known or underlying vascular disease and identifying those at high risk of a cardiac event is important for risk mitigation in patients with prostate cancer receiving hormone therapy. The GnRH antagonist degarelix conferred a significantly lower risk of cardiac events than GnRH agonists. Prior to treatment, patients should be stratified based on level of cardiovascular (CV) risk, and appropriate lifestyle, and pharmacological interventions to mitigate CV risk should be recommended. CV risk factors and patient response to the intervention should be monitored at regular intervals." @default.
- W3089336311 created "2020-10-01" @default.
- W3089336311 creator A5017678045 @default.
- W3089336311 creator A5020778309 @default.
- W3089336311 date "2020-09-26" @default.
- W3089336311 modified "2023-10-16" @default.
- W3089336311 title "Cardiovascular risk profiles of GnRH agonists and antagonists: real-world analysis from UK general practice" @default.
- W3089336311 cites W1720362365 @default.
- W3089336311 cites W1834366147 @default.
- W3089336311 cites W2003978261 @default.
- W3089336311 cites W2027791854 @default.
- W3089336311 cites W2049161486 @default.
- W3089336311 cites W2054377143 @default.
- W3089336311 cites W2059114395 @default.
- W3089336311 cites W2065300337 @default.
- W3089336311 cites W2075490674 @default.
- W3089336311 cites W2081052928 @default.
- W3089336311 cites W2082540132 @default.
- W3089336311 cites W2086158679 @default.
- W3089336311 cites W2097930057 @default.
- W3089336311 cites W2099037568 @default.
- W3089336311 cites W2102333999 @default.
- W3089336311 cites W2106458814 @default.
- W3089336311 cites W2116903603 @default.
- W3089336311 cites W2131170102 @default.
- W3089336311 cites W2135078918 @default.
- W3089336311 cites W2140905531 @default.
- W3089336311 cites W2141444154 @default.
- W3089336311 cites W2151247869 @default.
- W3089336311 cites W2165828486 @default.
- W3089336311 cites W2171665017 @default.
- W3089336311 cites W2327355331 @default.
- W3089336311 cites W2337137963 @default.
- W3089336311 cites W2474956410 @default.
- W3089336311 cites W2511755939 @default.
- W3089336311 cites W2596675526 @default.
- W3089336311 cites W2604801030 @default.
- W3089336311 cites W2605463036 @default.
- W3089336311 cites W2781525129 @default.
- W3089336311 cites W2903145654 @default.
- W3089336311 cites W2949925748 @default.
- W3089336311 cites W2979248581 @default.
- W3089336311 cites W2979622683 @default.
- W3089336311 cites W2984222631 @default.
- W3089336311 cites W3013064839 @default.
- W3089336311 cites W3020820143 @default.
- W3089336311 cites W3032046986 @default.
- W3089336311 cites W3104447906 @default.
- W3089336311 cites W4234513616 @default.
- W3089336311 cites W4243536795 @default.
- W3089336311 doi "https://doi.org/10.1007/s00345-020-03433-3" @default.
- W3089336311 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7910366" @default.
- W3089336311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32979057" @default.
- W3089336311 hasPublicationYear "2020" @default.
- W3089336311 type Work @default.
- W3089336311 sameAs 3089336311 @default.
- W3089336311 citedByCount "26" @default.
- W3089336311 countsByYear W30893363112021 @default.
- W3089336311 countsByYear W30893363112022 @default.
- W3089336311 countsByYear W30893363112023 @default.
- W3089336311 crossrefType "journal-article" @default.
- W3089336311 hasAuthorship W3089336311A5017678045 @default.
- W3089336311 hasAuthorship W3089336311A5020778309 @default.
- W3089336311 hasBestOaLocation W30893363111 @default.
- W3089336311 hasConcept C121608353 @default.
- W3089336311 hasConcept C126322002 @default.
- W3089336311 hasConcept C134018914 @default.
- W3089336311 hasConcept C143998085 @default.
- W3089336311 hasConcept C170493617 @default.
- W3089336311 hasConcept C2777899217 @default.
- W3089336311 hasConcept C2778575703 @default.
- W3089336311 hasConcept C2778894405 @default.
- W3089336311 hasConcept C2778938600 @default.
- W3089336311 hasConcept C2780192828 @default.
- W3089336311 hasConcept C2908647359 @default.
- W3089336311 hasConcept C44249647 @default.
- W3089336311 hasConcept C71315377 @default.
- W3089336311 hasConcept C71924100 @default.
- W3089336311 hasConcept C82789193 @default.
- W3089336311 hasConcept C99454951 @default.
- W3089336311 hasConceptScore W3089336311C121608353 @default.
- W3089336311 hasConceptScore W3089336311C126322002 @default.
- W3089336311 hasConceptScore W3089336311C134018914 @default.
- W3089336311 hasConceptScore W3089336311C143998085 @default.
- W3089336311 hasConceptScore W3089336311C170493617 @default.
- W3089336311 hasConceptScore W3089336311C2777899217 @default.
- W3089336311 hasConceptScore W3089336311C2778575703 @default.
- W3089336311 hasConceptScore W3089336311C2778894405 @default.
- W3089336311 hasConceptScore W3089336311C2778938600 @default.
- W3089336311 hasConceptScore W3089336311C2780192828 @default.
- W3089336311 hasConceptScore W3089336311C2908647359 @default.
- W3089336311 hasConceptScore W3089336311C44249647 @default.
- W3089336311 hasConceptScore W3089336311C71315377 @default.
- W3089336311 hasConceptScore W3089336311C71924100 @default.
- W3089336311 hasConceptScore W3089336311C82789193 @default.
- W3089336311 hasConceptScore W3089336311C99454951 @default.
- W3089336311 hasIssue "2" @default.
- W3089336311 hasLocation W30893363111 @default.